Inspiration Healthcare Group PLC Revenue and Profit Upgrade (6776M)
25 Enero 2021 - 01:00AM
UK Regulatory
TIDMIHC
RNS Number : 6776M
Inspiration Healthcare Group PLC
25 January 2021
Inspiration Healthcare Group plc
("Inspiration Healthcare", the "Company" or the "Group")
Revenue and Profit Upgrade
Inspiration Healthcare Group plc (AIM: IHC), the global medical
technology company, is pleased to announce that it has continued to
experience strong momentum since publishing its half year results
in October 2020, that Group revenues and EBITDA for the financial
year ending 31 January 2021 will exceed current market expectations
and that the Group expects to report turnover of not less than
GBP36.5 million and EBITDA(1) of not less than GBP4.9 million.
The key driver for this increase in revenues and profits has
been the strong performance achieved by S.L.E. Limited, the leading
designer and manufacturer of ventilators for neonatal intensive
care which was acquired by Inspiration Healthcare in July 2020 and
which has seen sales increase steadily during the period of its
integration into the Group. Additionally, operational efficiencies
already identified through the integration process have started to
be achieved.
Neil Campbell, Chief Executive Officer, commented: "I am
delighted to announce this increase in revenues and profits, which
has been achieved in a very tough environment and so clearly
demonstrates the quality of our products and services as well as
the level of commitment that all our teams have dedicated to
driving forward the growth of the Company this year. We remain very
well placed for the future with a strong balance sheet and many
opportunities for continued growth and we look forward with
confidence."
1 Earnings before interest, tax, depreciation, amortisation,
share based payments and exceptional items.
The information contained within this announcement is deemed to
constitute inside information as stipulated under the Market Abuse
Regulation (EU) No. 596/2014. Upon the publication of this
announcement, this inside information is now considered to be in
the public domain.
Enquiries:
Inspiration Healthcare Group plc Tel: 01455 840555
Neil Campbell, Chief Executive Officer
Jon Ballard, Chief Financial Officer
Nominated Adviser & Broker Tel: 0207 397 8900
Cenkos Securities plc
Mark Connelly
Stephen Keys
-------------------
Cadogan PR Tel: 07771 713608
Alex Walters
alex.walters@cadoganpr.com
-------------------
About Inspiration Healthcare http://www.inspiration-healthcare.com
Inspiration Healthcare (AIM: IHC) is a global provider of
medical technology for use in critical care & operating
theatres. The Company provides high-quality, innovative products to
patients around the world which help to improve patient outcomes,
and it actively invests in innovative product opportunities and
disruptive technologies.
Through investment in research and development the Company has
six key own-brand products that can be used within the first 6
hours of life to help premature and sick babies; helping with
assessment, resuscitation, stabilisation as well as preventing
brain damage. Additionally, the Company has a range of products for
maintaining normothermia pre- during and post-surgery.
In September 2019, the Company acquired Vio Holdings a designer,
manufacturer and supplier of single-use respiratory products and
sterile medical consumables for GBP3.7 million and in June 2020 the
Company acquired SLE, a leading global provider of neonatal
ventilation products for GBP18 million. Over 90% of SLE's revenues
are generated from sales outside of the UK with a significant
proportion of these in the Asia Pacific and the Middle East. When
combined, the Group generates approximately 60 per cent. of its
revenue from exports.
With product availability extending to over 50 countries through
a distribution network, Inspiration Healthcare's success has been
built on continuous innovation, excellent customer service and an
inherent commitment to improving patient outcomes, working in close
collaboration with key opinion leaders across the globe.
In the U.K. and Ireland, the Company has a direct sales team
selling Inspiration Healthcare Branded and complementary products
from third parties, with an additional range of home healthcare
products. This is supported by Technical Support for planned
preventative maintenance and emergency assistance.
Further information on Inspiration Healthcare can be seen at www.inspiration-healthcare.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCFIFFSLFISFIL
(END) Dow Jones Newswires
January 25, 2021 02:00 ET (07:00 GMT)
Inspiration Healthcare (LSE:IHC)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024
Inspiration Healthcare (LSE:IHC)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024